Duratocin 100 mcg (Carbetocin SOLUTION) 100 MCG

Duratocin 100 mcg is a solution containing Carbetocin, used for specific medical conditions. This intramuscular solution is manufactured by Ferring Inc. in Canada.

Strength

100 MCG

Manufacturer / TM Owner

FERRING INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Duratocin 100 mcg is primarily used to manage certain conditions related to uterine health. Carbetocin, the active ingredient, is often utilized in scenarios requiring uterine contraction. It is important to consult a healthcare provider to determine the appropriate use of Duratocin 100 mcg.

Side Effects

Common effects of Duratocin 100 mcg may include temporary discomfort at the injection site. Some individuals might experience mild to moderate side effects, which typically subside over time. Always monitor your body's response and report any persistent or severe effects to your healthcare provider.

Precautions & Warnings

Duratocin 100 mcg should be handled with care, ensuring proper storage and administration. It is crucial to follow the instructions provided by your healthcare provider to minimize any potential risks. Always inform your healthcare provider about any pre-existing conditions or allergies before using this solution.

Avoid Interactions

Duratocin 100 mcg may interact with certain medications, including those that affect blood pressure or other uterine-related treatments. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Additionally, alcohol and other substances may influence the effects of Duratocin 100 mcg.

Frequently Asked Questions

Duratocin 100 mcg is used to manage certain conditions related to uterine health, often involving the need for uterine contraction.

Duratocin 100 mcg is administered intramuscularly, typically by a healthcare professional.

Common side effects may include temporary discomfort at the injection site and mild to moderate side effects that usually subside over time.

The use of Duratocin 100 mcg during pregnancy should be discussed with a healthcare provider, as it depends on individual circumstances.

If you experience severe or persistent side effects, it is important to contact your healthcare provider immediately.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.